Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
24.76 USD | +0.39% | -1.74% | +29.62% |
May. 13 | Piper Sandler Adjusts Price Target on Myriad Genetics to $28 From $23, Maintains Neutral Rating | MT |
May. 08 | Sector Update: Health Care Stocks Softer Late Afternoon | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+29.62% | 2.23B | |
-4.57% | 12.32B | |
-4.35% | 8.1B | |
+8.91% | 5.87B | |
+30.69% | 5.52B | |
-7.42% | 4.29B | |
-54.11% | 3.16B | |
+14.44% | 2.72B | |
-2.21% | 2.37B | |
-4.67% | 1.87B |
- Stock Market
- Equities
- MYGN Stock
- News Myriad Genetics, Inc.
- Insider Sell: Myriad Genetics